Pain Improvement in Parkinson´s Disease Treated wirh Safinamide. Results from the SAFINONMOTOR Study enero 12, 1919enero 12, 2023
Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study enero 12, 1919enero 12, 2023
Safinamide Improves Sleep and Daytime Sleepiness in Parkinson´s Disease. Results from the SAFINONMOTOR Study enero 12, 1919enero 12, 2023
Vortioxetina mejora el estado de ánimo y la función cognitiva en pacientes con enfermedad de Parkinson y depresión mayor. Resultados del estudio VOPARK. enero 12, 1919enero 12, 2023
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study enero 12, 1919enero 12, 2023